A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience


Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., ÖZKOCAMAN V., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.36, sa.4, ss.230-237, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 4
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4274/tjh.galenos.2019.2018.0307
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.230-237
  • Anahtar Kelimeler: Thrombocytopenia, Immune thrombocytopenic, Eltrombopag, LONG-TERM, PURPURA, SAFETY, ADULTS, ITP
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP).